Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NovaMed Pharmaceuticals Inc.

Division of SciClone Pharmaceuticals Inc.
www.novamed.com.cn

Latest From NovaMed Pharmaceuticals Inc.

Chinese Investor Consortium Buys SciClone But Relisting Possible

Against a background of positive changes to regulations and policies on pharmaceutical marketing in China, US-based SciClone has accepted a buyout offer from a consortium of Chinese investors, but may relist in China in the future.

China Commercial

Death By EDL Inclusion? Pfizer And SciClone Drop Cancer Drugs In China

Manufacturers are reevaluating products and reducing sales forces in response to pricing pressure that includes an expanded Essential Drug List in China.

BioPharmaceutical China

Death By EDL Inclusion? Pfizer And SciClone Drop Cancer Drugs In China

Manufacturers are reevaluating products and reducing sales forces in response to pricing pressure that includes an expanded Essential Drug List in China.

BioPharmaceutical China

With An Eye On China’s Growing PAD Market, SciClone Teams Up With Taiwan Liposome Co.

Looking to take on Bayer/UCB’s Prostavasin and a local blockbuster from Beijing Tide Pharmaceutical Co., SciClone will jump into China’s peripheral arterial disease market with what it hopes is a differentiated product developed by TLC.

BioPharmaceutical China
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • SciClone Pharmaceuticals Inc.
  • Senior Management
  • Contact Info
  • NovaMed Pharmaceuticals Inc.
    Phone: (86) 21 6375 9333
    227 North Huang Pi Rd., Cental Plaza
    Rm. 2601
    Shanghai, 200003
    China
Advertisement
Advertisement
UsernamePublicRestriction

Register